Hexarelin 5mg
Most Potent GHRP with Cardiac Protective Properties
Hexarelin is the most potent synthetic GHRP available, producing the largest GH pulses among GHRPs. Uniquely, it also activates CD36 receptors independent of GH for direct cardioprotective and anti-atherogenic effects in cardiac research.
Most Potent GHRP with Cardiac Protective Properties
Hexarelin (Examorelin) combines potent GHS-R1a activation with CD36 receptor agonism. The CD36 pathway provides direct cardiac protection, reduces myocardial ischemia damage, and has anti-atherosclerotic properties independent of GH — a unique dual mechanism.
As one of the most studied compounds in the growth & body comp research space, Hexarelin has attracted sustained scientific interest across Maximum GH secretagogue research, Cardiac protection studies, CD36 receptor biology. Peer-reviewed evidence indicates that most potent GHRP for GH release, which has positioned Hexarelin as a reference standard for researchers exploring maximum gh secretagogue research outcomes. The compound's selectivity and documented tolerability in preclinical models have contributed to a rapidly growing body of literature over the past decade.
Hexarelin Documented Benefits: 3 Documented Mechanisms
Maximum GH Potency
Most potent synthetic GHRP; produces the largest GH pulses for maximal GH secretagogue research.
Cardiac Protection
Direct CD36 receptor activation provides myocardial protection independent of GH release.
Anti-Atherogenic
CD36 agonism reduces atherosclerotic plaque in preclinical models.
How Hexarelin Works: Molecular Mechanism & Pathway
Most potent GHS-R1a agonist; additionally activates CD36/scavenger receptor for GH-independent cardioprotective and anti-atherogenic effects.
The 3 primary research pathways identified for Hexarelin — Maximum GH Potency, Cardiac Protection, Anti-Atherogenic — collectively point to a compound with pleiotropic activity across interconnected biological systems. Studies have further shown that cardiac protection via CD36 independent of GH, reinforcing the mechanistic picture established in earlier cell-line work. Unlike single-pathway agents, Hexarelin's broad receptor engagement profile continues to generate hypotheses for novel applications beyond its originally characterized use cases.
Research Protocols & Compound Combinations
Hexarelin is routinely studied alongside SS-31 and Ipamorelin in growth & body comp-focused compound panels. Researchers investigating maximum gh secretagogue research have found that pairing compounds with complementary receptor profiles can produce additive results while keeping individual doses within well-characterized ranges. Preliminary evidence that reduces myocardial damage in ischemia models has informed several of these multi-compound protocol designs.
Purity, Testing & Research Grade Standards
All Hexarelin research material offered through this catalog is manufactured under controlled conditions and independently verified by a third-party laboratory prior to release. Each lot undergoes High-Performance Liquid Chromatography (HPLC) analysis to confirm ≥98% purity, with identity confirmed via mass spectrometry. The accompanying Certificate of Analysis (CoA) documents the exact purity, molecular weight confirmation, and lot-specific testing date — data that should accompany any reproducible research protocol. Lyophilized powder formulation ensures maximum stability during shipping and storage at −20°C long-term or 4°C for short-term use.
◈ Key Highlights
- Most potent GHRP for GH release
- Cardiac protection via CD36 independent of GH
- Reduces myocardial damage in ischemia models
Ideal For
- Maximum GH secretagogue research
- Cardiac protection studies
- CD36 receptor biology
Intended for laboratory use only. Not for human or animal consumption. Not FDA approved. Handle in appropriate lab settings only.
What the Research Shows
The following data points are derived from peer-reviewed preclinical and clinical studies on Hexarelin. All studies cited in compound profiles are indexed in PubMed or published in peer-reviewed journals.
Most potent GHRP for GH release
Cardiac protection via CD36 independent of GH
Reduces myocardial damage in ischemia models
Third-Party Verified Every Batch
Each vial of Hexarelin is independently tested by a third-party laboratory before fulfillment. You receive the actual CoA (Certificate of Analysis) documentation with your order.
